Healthcare

Oxford provides $43.3 mln to Continuing Healthcare Solutions

Oxford Finance LLC has provided a $43.3 million loan to Middleburg Heights, Ohio-based Continuing Healthcare Solutions Inc, a provider of healthcare services to senior citizens. The capital was used to buy and provide working capital for eight long-term care facilities in Ohio from the Zandex Group.

Monumet recaps MDME

Monument MicroCap Partners LLC has recapitalized Montgomery DME, a provider of durable medical equipment to hospices located primarily in Los Angeles and surrounding counties. No financial terms were disclosed.

Amid Covetrus IPO, CD&R's Vets First Choice stake valued at ~5x investment

Churchill provides $90 mln to back Morgan Stanley's acquisition of Clarity

Churchill Asset Management LLC has provided $90 million in financing to back Morgan Stanley Capital Partners' acquisition of Clarity Software Solutions, a data and technology driven provider of communication solutions for healthcare payers. Churchill was the sole lead arranger on the financing.

Veritas and Elliott's Evergreen completes take-private buyout of Athenahealth

Veritas Capital and Elliott Management's Evergreen Coast Capital have closed its previously announced take-private acquisition of Athenahealth, a provider of medical record, revenue cycle, patient engagement, care coordination and population health services. The price of the deal was about $5.7 billion. Veritas portfolio company Virence Health will merge with Athenahealth and operate under the Athenahealth name. As a result of the closing, Athenahealth stock will be delisted from the NASDAQ and stop trading after the February 11, 2019 business day.

Francisco Partners buys Qualcomm Life

Francisco Partners said Feb. 11 that it acquired Qualcomm Life Inc from Qualcomm Inc. Financial term weren’t announced. Qualcomm Life will be renamed Capsule Technologies Inc and operate two business segments: Capsule, a medical device connectivity platform, and 2net, which provides wireless mobile device connectivity via cloud-based solutions.

Varsity's Emergency Care Partners merges with northeastern peer, adds Regal Healthcare to investor base

VC-backed Harpoon Therapeutics debuts IPO

South San Francisco-based Harpoon Therapeutics Inc, a clinical-stage immunotherapy company, has raised $75.6 million for its IPO after pricing its 5.4 million shares at $14 per share. The stock began trading February 8, 2019 on the NASDAQ under the ticker symbol "HARP." Citigroup and SVB Leerink are the lead underwriters. Harpoon's pre-IPO backers include OrbiMed, Cormorant, Ridgeback Capital Investments, Lilly Asia Ventures, NS Investment, MPM Capital, Oncology Impact Fund, Arix Bioscience, New Leaf Venture Partners and Taiho Ventures LLC.

VC-backed Gossamer Bio goes public

San Diego-based biopharmaceutical company Gossamer Bio has raised $276 million for its IPO after pricing its 17.25 million shares at $16 per share. The stock began trading February 8, 2019 on the NASDAQ under the ticker symbol "GOSS." BofA Merrill Lynch, SVB Leerink, Barclays and Evercore ISI are the lead underwriters. Gossamer's pre-IPO backers include Omega Funds and and ARCH Venture Partners.

Via M&A, GTCR's Resonetics doubles revenue in a year